Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity

Details for Australian Patent Application No. 2006208638 (hide)

Owner Novartis AG

Inventors Mestan, Juergen; Martiny-Baron, Georg; Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-B-2006208638

PCT Pub. Number WO2006/079539

Priority 60/647,895 28.01.05 US; 60/662,404 16.03.05 US

Filing date 26 January 2006

Wipo publication date 3 August 2006

Acceptance publication date 4 March 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/079539 Priority application(s): WO2006/079539

4 March 2010 Application Accepted

  Published as AU-B-2006208638

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208641-Device for milling rock and other materials and method for milling rock or the like using said device

2006208631-Production of antibodies in plants with plus -sense single -stranded viral RNA vectors